6/10
Breen has hit his stride, but takes on too much for one filmmaker
4 September 2023
In short: A wealthy benefactor funds a hospital to study genome editing that is plagued by black-market medicine theft and poor maintenance.

Neil Breen makes many decisions in this film that, if they were part of a more complete and coherent vision, would be bold and truly represent ambitious B-movie filmmaking.

Aesthetically: The entire movie is shot in green screen, over stock photos. Establishing shots are also stock footage. This is really exciting to me; it represents a really interesting way to do a film on a budget and nobody else would dare to do a film that way.

Narratively: The first 20 minutes of this movie has a lot going on, and it honestly made me wonder if Breen had learned from his previous films. He's certainly learned a few editing tricks. But as the film continues, it's clear that Breen still hasn't figured out how to write a plot with a beginning, middle, and end; scenes happen in seemingly random order and repeat information.

And as usual for Breen, characters speak vaguely without specific details or characterization. This is especially frustrating because it feels like this film, of all his post-Fateful Findings films, really has a clear and interesting premise.

Ultimately I came out of this film really wanting to see Breen direct another writer's work, or another writer direct a Breen screenplay. Both the central narrative idea and the directorial style have interesting things to say, but they both need some external contribution to really make them click.
9 out of 14 found this helpful. Was this review helpful? Sign in to vote.
Permalink

Recently Viewed